Paxil Birth Defect Lawsuit Settlements Reach $1 Billion
Posted by Jared Green on July 22, 2010
GlaxoSmithKline, the manufacturer of Paxil, has reportedly agreed to settle some 800 Paxil birth defect lawsuits for the sum of $1 billion. The Paxil settlements will pay individual families approximately $1.2 million.
The remaining 100 Paxil lawsuits include three that are set for trial later this year in Philadelphia.
Paxil is a controversial anti-depressant drug that has been linked to birth defects in pregnant mothers who were taking the drug. Such birth defects include cardiac problems and pulmonary hypertension.
Contact Jared Green:
1-800-662-6230 or jgreen@arbd.com
